¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"proton density contrast"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • color contrast
    »ö´ëºñ, »ö´ëÁ¶
  • contrast
    1. ´ëÁ¶, ´ëºñ 2. ´ëÁ¶µµ
  • contrast agent
    Á¶¿µÁ¦
  • contrast bath
    ¿Â³Ã±³´ë¸ñ¿å
  • contrast echocardiography
    Á¶¿µ½É(Àå)ÃÊÀ½ÆÄ°Ë»ç, Á¶¿µ½É(Àå)ÃÊÀ½ÆÄ(¼ú)
  • contrast enema
    1. Á¶¿µ°üÀå 2. Á¶¿µ°üÀå¾×
  • contrast enhancement
    Á¶¿µÁõ°­
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
  • contrast material
    Á¶¿µÀç
  • contrast media
    Á¶¿µÁ¦
  • contrast medium
    Á¶¿µÁ¦
  • contrast stain
    ´ëÁ¶¿°»ö
  • contrast staining
    ´ëÁ¶¿°»ö(¹ý)
  • contrast to noise ratio
    ´ëÁ¶´ëÀâÀ½ºñ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • high density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹é
  • low density lipoprotein
    Àú¹ÐµµÁöÁú´Ü¹é
  • very low density lipoprotein
    ÃÊÀú¹ÐµµÁöÁú´Ü¹é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • 3D phase contrast angiography
    »ïÂ÷¿øÀ§»ó´ëÁ¶Ç÷°üÁ¶¿µ¼ú
  • contrast agent
    Á¶¿µÁ¦
  • barium contrast medium
    ¹Ù·ýÁ¶¿µÁ¦
  • binocular contrast
    ¾ç¾È´ëºñ, µÎ´«´ëºñ
  • blood oxygenation level dependant contrast
    Ç÷Áß»ê¼ÒÄ¡ÀÇÁ¸´ëÁ¶µµ
  • contrast bath
    ¿Â³Ã±³´ë¸ñ¿å
  • contrast
    ´ëÁ¶
  • color contrast
    »ö´ëºñ, »ö´ëÁ¶
  • contrast echocardiography
    Á¶¿µ½ÉÀåÃÊÀ½ÆÄ°Ë»ç, Á¶¿µ½ÉÃÊÀ½ÆÄ°Ë»ç
  • contrast enema
    Á¶¿µ°üÀå
  • contrast enhancement
    Á¶¿µÁõ°­
  • contrast material
    Á¶¿µÀç
  • contrast media
    Á¶¿µÁ¦
  • contrast medium
    Á¶¿µÁ¦
  • contrast stain
    ´ëÁ¶¿°»ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hepato-renal echo contrast
    °£-½ÅÀå (ÊÜ-ãìíô) ¿¡ÄÚ ´ëÁ¶ (ÓßðÎ), °£-½ÅÀå (ÊÜ-ãì
  • phase contrast
    À§»ó ´ëÁ¶
  • phase contrast (PC) MR angiography
    À§»ó ´ëÁ¶ ÀÚ±â°ø¸í Ç÷°üÁ¶¿µ¼ú
  • phase contrast microscopy
    À§»óÂ÷(êÈßÓó¬)Çö¹Ì°æ°Ë»ç
  • phase-contrast microscopy
    À§»óÂ÷Çö¹Ì°æ
  • positive contrast medium
    ¾ç¼º Á¶¿µÁ¦
  • pre contrast enhanced image
    Á¶¿µ Áõ°¡Àü ¿µ»ó
  • HDL (High-density lipoproteins)
    °í¹ÐµµÁö´Ü¹éÁú(ÍÔÚËÓøò·Ó±ÛÜòõ)
  • High-density lipoprotein = HDL
    °í¹ÐµµÁö´Ü¹éÁú(ÍÔÚËÓøò·Ó±ÛÜòõ)
  • IDL = intermediate density lipoprotein
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate density lipoprotein =IDL
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • LDL = low density lipoprotein
    Àú¹ÐµµÁö´Ü¹é(î¸ÚËÓøò·Ó±ÛÜ)
  • REM density
    ·½¹Ðµµ
  • VLDL => very low density lipoprotein
    ÃÊÀú¹ÐµµÁö ´Ü¹éÁú
  • amorphous density
    ¹«Á¤Çü ¹Ðµµ(ÙíïÒúþ ÚËÓø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • proton flow abnormality
    ¾çÀÚ À¯µ¿ ÀÌ»ó
  • proton flow deficit
    ¾çÀÚ À¯µ¿ °áÇÌ
  • proton radiation therapy
    ¾çÀÚ¼±Ä¡·á
  • proton relaxation
    ¾çÀÚ ÀÌ¿Ï
  • proton relaxation enhancement
    ¾çÀÚ ÀÌ¿Ï Áõ°­
  • proton shift
    ¾ç¼ºÀÚÀ̵¿(åÕàõí­ì¹ÔÑ).
  • pseudodiastole in high intensity proton flow
    °í°­µµ ¾çÀÚ À¯µ¿¿¡¼­ À§À̿ϱâ
  • recoil proton
    ¹Ýµµ¾çÀÚ
  • replaceable proton
    ´ëü¾çÀÚ
  • shielding proton
    Â÷Æó ¾çÀÚ
  • barium contrast medium
    ¹Ù·ý Á¶¿µÁ¦
  • binocular contrast
    ¾ç¾È´ëºñ(¡­ÓßÝï).
  • blood oxygenation level dependant contrast
    Ç÷Áß »ê¼ÒÄ¡ ÀÇÁ¸ ´ëÁ¶µµ
  • colo(u)r contrast
    »ö´ëºñ(ßäÓßÝï).
  • color contrast
    »ö´ëºñ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • charge density
    ÀüÇϹеµ(ï³ùÃÚËÓø)
  • continuous density gradient
    ¿¬¼Ó¹Ðµµ±¸¹è(Ö§áÙÚËÓøÎþÛÕ)
  • density
    ¹Ðµµ(ÚËÓø)
  • density-dependent growth
    "¹ÐµµÀÇÁ¸ ¼ºÀå(ÚËÓøëîðíà÷íþ), (ÔÒ) contact inhibition"
  • density gradient
    ¹Ðµµ±¸¹è(ÚËÓøÎþÛÕ)
  • density gradient centrifugation
    ¹Ðµµ±¸¹è ¿ø½ÉºÐ¸®(ÚËÓøÎþÛÕêÀãýÝÂ×î)
  • density gradient sedimentation equilibrium
    ¹Ðµµ±¸¹è ħ°­ ÆòÇü(ÚËÓøÎþÛÕöØË½øÁû¬)
  • density gradient sedimentation velocity
    ¹Ðµµ±¸¹è ħ°­ ¼Óµµ(ÚËÓøÎþÛÕöØË½áÜÓø)
  • density gradient zonal centrifugation
    "¹Ðµµ±¸¹è ¿ª¿ø½ÉºÐ¸®(ÚËÓøÎþÛÕæ´êÀãýÝÂ×î), (ÔÒ) density gradient sedimentation velocity"
  • density inhibition
    "¹ÐµµÀúÇØ(ÚËÓøîÁúª), (ÔÒ) contact inhibition"
  • discontinuous density gradient
    ºÒ¿¬¼Ó ¹Ðµµ±¸¹è(ÝÕææáÙÚËÓøÎþÛÕ)
  • exponential density gradient
    Áö¼ö ³óµµ ±¸¹è (ò¦â¦ÒØÓøÎøÛÎ)
  • familial high-density lipoprotein deficiency °¡Á·¼º °í¹Ðµµ ÁöÁú´Ü¹éÁú °áÇÌ (Ê«ðéàõÍÔÚËÓøò·òõ
    Ó±ÛÜòõÌÀù¹)
  • high-density lipoprotein
    °í¹Ðµµ ÁöÁú´Ü¹éÁú(ÍÔÚËÓøò·òõÓ±ÛÜòõ)
  • linear density gradient
    ¼± ¹Ðµµ(à»ÚËÓø)±â¿ï±â
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • high intensity proton flow
    °í°­µµ¾çÀÚÀ¯µ¿
  • interstitial density
    °£Áú¼ºÀ½¿µ
  • linear density
    ¼±»óÀ½¿µ
  • lipid bound proton
    Áö¹æ°áÇվ缺ÀÚ
  • low intensity void in proton flow
    ¾ç¼ºÀÚÈ帧ÀÇ Àú°­µµ¼Ò½Ç
  • magnetic flux density
    ÀÚ±âÀ¯µ¿¹Ðµµ
  • middle density
    Áß°£À½¿µ, Áß°£¹Ðµµ
  • nodular density
    °áÀý¼ºÀ½¿µ
  • nonsaturated proton
    ºñÆ÷È­¾çÀÚ
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º¾çÀÚÀÌ¿ÏÁõ°­
  • perihilar density
    Æó¹®ÁÖÀ§À½¿µ
  • pixel density
    Çȼ¿À½¿µ, È­¼ÒÀ½¿µ
  • proton
    ¾ç¼ºÀÚ
  • proton electron dipole dipole interaction
    ¾çÀÚÀüÀÚ½Ö±ØÀÚ½Ö±ØÀÚ»óÈ£¹ÝÀÀ
  • proton flow
    ¾çÀÚÀ¯µ¿
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PMF platelet membrane fluidity; progressive massive fibrosis; proton motive force; pterygomaxillary foss...
pmf proton motive force
PMR patient meta-record; perinatal mortality rate; periodic medical review; physical medicine and rehabi...
PRE photoreacting enzyme; physician's report of examination; pigmented retinal epithelium; preplacement ...
PRR proton relaxation rate; pulse repetition rate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PMR Proton magnetic resonance
PMF Proton motive force
V-ATPase Vacuolar proton-translocating ATPases
PRR proton relaxation rate
PRF proton resonance frequency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • contrast material
    Á¶¿µ ¹°Áú, Á¶¿µÁ¦
  • contrast medium
    Á¶¿µÁ¦
    ¾î¶² Á¶Á÷À̳ª °ø°£À» ¹æ»ç¼± ºÒÅõ°ú¼ºÀ¸·Î ¸¸µå´Â ¿µ»ó °Ë»ç¿¡ ¾Õ¼­ ÁÖ»çÇÏ´Â ¹æ»ç¼± ºÒÅõ°ú¼º ¹°Áú.
  • double contrast
    ÀÌÁß Á¶¿µ¼ú
  • double contrast arthrography
    ÀÌÁß °üÀý Á¶¿µ¼ú, ÀÌÁß Á¶¿µ °üÀý Á¶¿µ¼ú
  • hepato renal echo contrast
    °£ ½ÅÀå ¿¡ÄÚ ´ëÁ¶
  • magnetic transfer contrast
    ÀÚÈ­ Àü´Þ ´ëÁ¶µµ
  • phase contrast
    À§»ó ´ëÁ¶
  • pre-contrast enhanced image
    Á¶¿µ Áõ°­Àü ¿µ»ó
  • radiographic contrast
    ¹æ»ç¼± »çÁø ´ëÁ¶
  • radiopaque contrast medium
    ¹æ»ç¼± ºÒÅõ°ú¼º Á¶¿µÁ¦
  • single contrast arthrogram
    ´ÜÀÏ ´ëºñ °üÀý Á¶¿µ »çÁø
  • single-contrast arthrography
    ´ÜÀÏ °üÀý Á¶¿µ¼ú
    °üÀý ¿øÆÇÀÇ À§Ä¡, ¿¬Á¶Á÷ ¿ÜÇü, õ°øÀÇ À¯¹«, °üÀý ¿îµ¿, °üÀý³» À̹°Áú, À¯Âø¼º °üÀý³¶¿°À» Æ÷ÇÔÇÏ´Â °üÀý³» ¿¬Á¶Á÷ÀÇ À§Ä¡¿Í ¿ÏÀü¼ºÀ» È®ÀÎÇϱâ À§ÇØ °üÀý°­ ³»¿¡ ¹æ»ç¼± ºÒÅõ°ú¼º Á¶¿µÁ¦¸¦ ÁÖ»çÇÑ ÈÄ ÃÔ¿µÇÑ °üÀý »çÁø.
  • tissue contrast
    Á¶Á÷ ´ëÁ¶µµ
  • water soluble contrast media
    ¼ö¿ë¼º Á¶¿µÁ¦
  • absolute density
    Àý´ë ¹Ðµµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
count density The number of counted events recorded in scintigraphy per square centimeter or per square inch of imaged area.
Synonym: count density.
(05 Mar 2000)
population density <epidemiology> Number of individuals in a population relative to space.
(12 Dec 1998)
current density <radiobiology> Amount of current flowing through a substance, per unit area perpendicular to the direction of current flow. (See also density)
(09 Oct 1997)
high density lipoprotein <biochemistry> These lipoproteins acts to carry cholesterol in the bloodstream.
Raised high density lipoprotein levels have been correlated with a lower risk for heart disease. Less than 35 mg/dl is considered a positive risk factor for coronary artery disease, over 60 mg/dl is considered a negative risk factor (reduces your risk of heart disease).
Recent studies show a low high density lipoprotein level is the strongest predictor of cardiovascular death in women.
Acronym: HDL
(18 Nov 1997)
spin density The number of nuclear dipoles per unit volume.
(05 Mar 2000)
stand density The number or mass of trees occupying a site. It is usually measured in terms of stand density index or basal area per acre.
(05 Dec 1998)
neutral-density filter <equipment> A light-absorbing filter whose absorption spectrum is moderately flat. Depending on the type, the absorption curve is flat primarily in the visible spectral range, or may extend to varying degrees beyond the visible range. For video microscopy, this is an important point since the absorbance may or may not extend into the near-infrared region where the sensitivity of many video image pickup devices is very high.
(05 Aug 1998)
density 1. <radiology> The amount of darkness or light in an area of a scan reflects the compactness and density of tissue. Differences in tissue density are the basis for CT and MR scans.
2. <microscopy> Logarithm to the base 10 of the reciprocal of transmittance.
(12 Jan 1998)
density-dependent <epidemiology> 1. Effects whose intensity changes with increasing population density.
2. Effects whose intensity increases with increasing population density, for example a mortality which becomes very high near a carrying capacity. Effects which become less pronounced at higher population sizes (perhaps the reduction in fecundity caused by the difficulty of mating) are sometimes called inverse density dependent. Density dependent effects are often a cause of nonlinearity in a model.
(05 Dec 1998)
density dependent inhibition of growth <cell culture> The phenomenon exhibited by most normal (anchorage dependent) animal cells in culture that stop dividing once a critical cell density is reached.
The critical density is considerably higher for most cells than the density at which a monolayer is formed, for this reason, most cell behaviourists prefer the term density dependent inhibition of growth as this avoids any confusion with contact inhibition of locomotion, a totally different phenomenon that is contact dependent.
(12 Jan 1998)
density gradient <chemistry> A column of liquid in which the density varies continually with position, usually as a consequence of variation of concentration of a solute.
Such gradients may be established by progressive mixing of solutions of different density as for example: sucrose gradients) or by centrifuge induced redistribution of solute (as for caesium chloride gradients).
Density gradients are widely used for centrifugal and gravity induced separations of cells, organelles and macromolecules. The separations may exploit density differences between particles or primarily differences in size, in which latter case the function of the gradient is chiefly to stabilise the liquid column against mixing.
(12 Jan 1998)
density gradient centrifugation <technique> High-speed centrifugation inwhich molecules float at a point wheretheir density equals that in a gradient of cesium chloride or sucrose.
(12 Jan 1998)
incidence density The person-time incidence rate.
(05 Mar 2000)
intermediate density lipoprotein Class of lipoproteins formed in degradation of very-low-density lipoproteins; about half are cleared quickly from the plasma into the liver by receptor-mediated endocytosis; the other half are degraded into low density lipoproteins.
(05 Mar 2000)
inverse density dependence <epidemiology> See density dependence.
(05 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á